Jenburkt Pharmaceuticals informs about loss of share certificate

09 Aug 2023 Evaluate

Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and disclosure Requirements) Regulations, 2015, Jenburkt Pharmaceuticals has informed regarding loss of share certificate(s) received on 8th August, 2023 from the shareholder, Anil Ramesh Patel (Folio No: A000686) as details enclosed. The company is in the process of issuing Letter of Confirmation, after compliance of required formalities.

The above information is a part of company’s filings submitted to BSE. 

Jenburkt Pharma Share Price

1071.30 31.30 (3.01%)
03-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1770.10
Dr. Reddys Lab 1151.25
Cipla 1495.15
Lupin 2094.50
Zydus Lifesciences 901.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...